UGI Corporation to Hold 2QFY21 Earnings Conference Call and Webcast on Thursday, May 6
- Wall Street slips off record highs, Tesla drops after fatal crash
- IBM (IBM) Tops Q1 EPS by 14c, Revenue Beats
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
VALLEY FORGE, Pa.--(BUSINESS WIRE)-- UGI Corporation (NYSE:UGI) will announce the results of its second fiscal quarter earnings after the market closes on May 5. The company will hold a live internet audio webcast of its conference call to discuss results and other current activities at 9:00 AM ET on Thursday, May 6.
Interested parties may listen to the audio webcast both live and in replay on the Internet at https://www.ugicorp.com/investors/financial-reports/presentations or by visiting the company website https://www.ugicorp.com and clicking on Investors and then Presentations.
A telephonic replay will be available from 12:00 PM ET on May 6 through 11:59 PM ET May 13. The replay may be accessed toll free at 855-859-2056 and internationally at +1 404-537-3406, conference ID 2876774.
UGI Corporation is a distributor and marketer of energy products and services. Through subsidiaries, UGI operates natural gas and electric utilities in Pennsylvania, distributes LPG both domestically (through AmeriGas) and internationally (through UGI International), manages midstream energy assets in Pennsylvania, Ohio, and West Virginia and electric generation assets in Pennsylvania, and engages in energy marketing, including renewable natural gas, in twelve states and the District of Columbia and internationally in France, Belgium, the Netherlands and the UK.
Comprehensive information about UGI Corporation is available on the Internet at https://www.ugicorp.com.
CONTACT INVESTOR RELATIONS
Tameka Morris, ext. 6297
Arnab Mukherjee, ext. 7498
Shelly Oates, ext. 3202
Source: UGI Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herman Miller (MLHR) to Acquire Knoll (KNL) for $1.8 Billion in Cash in Stock
- GlucoModicum’s non-invasive glucose monitoring technology performs 13x better than previous needle-free approaches
- Quantum Genomics Announces the End of its Collaboration with Qilu for the Development and Commercialization of Firibastat in China